HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Clinical trials for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA explained in plain language.
Never miss a new study
Get alerted when new HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA trials appear
Sign up with your email to follow new studies for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Editing heart therapy under 15-Year watch
Disease control ENROLLING_BY_INVITATIONThis study follows 116 people who received an experimental gene-editing therapy for heart disease or high cholesterol. Researchers will monitor them for 15 years to track any side effects and how well the treatment controls cholesterol levels. The goal is to understand the long-t…
Matched conditions: HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Sponsor: Verve Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Real-World study tracks cholesterol drug inclisiran in heart patients
Knowledge-focused OngoingThis observational study follows about 198 patients in Spain who are already taking inclisiran (Leqvio) for high cholesterol linked to heart disease or a genetic condition. Researchers will check if patients reach their LDL cholesterol goals after 6 and 12 months. The goal is to …
Matched conditions: HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC